OccamPoint

Apply to Speak at OccamPoint Webinar: Share Your Healthcare Innovations with the World! Are you a leader in healthcare, life sciences, or medical devices? Do you have groundbreaking technological or methodological breakthroughs to share? Here's your chance to elevate your impact and connect with a global network of experts! Why Speak at OccamPoint Webinar? Showcase Your Innovations: Gain a valuable platform to present your cutting-edge solutions to a curated audience of thousands in the product development and investment communities. Expand Your Network: Connect with industry leaders and professionals without the hassle and cost of traditional conferences. Real Impact: Rick Landin, CEO of Telperian Inc, shared “The OccamPoint Webinar provided Telperian Inc with a valuable stage to showcase our innovations, offering a refreshing departure from the usual time- and cost-intensive conference format. This shift not only benefited our company but also extended to participants worldwide, who could join without the hassle of travel. As we connected with attendees online, they seamlessly became part of our network. From this network, we've garnered three promising leads for future collaborations, which we are actively pursuing.” Imagine what it could do for your organization! Join the Global Stage: Our mission is to elevate awareness about technological and methodological breakthroughs that can significantly enhance product development success rates and efficiency. Present your ideas, inspire others, and drive innovation forward. The OccamPoint Webinar is your opportunity to make a difference in the future of healthcare and life sciences. Apply Now: https://lnkd.in/gM3SZV5P Let’s innovate, inspire, and transform the industry together! #Innovation #Healthcare #LifeSciences #MedicalDevices #Webinar #ProductDevelopment #TechBreakthroughs #OccamPointWebinar #HealthcareStartups #StartUpLaunch #NewStartUps #DrugApproval?#MedicalApproval #MedicalResearch #HealtcareDevelopment #DrugLaunch

Announcing next OccamPoint Webinar: Harmonizing #CRO and #Sponsor Expectations in #Outsourced TMF Management: ?? Wednesday, April 16, 2025 ?? 1:00 - 2:00 PM PST | 4:00 - 5:00 PM EST ?? Register: https://lnkd.in/gwvKZxnT Emerging #clinicaltrial sponsors often rely on CROs for #Trial Master File (#TMF) management—but oversight and compliance? That responsibility still falls on them. Too many small #biotech sponsors underestimate early TMF oversight, leading to: ? Costly remediation at #trialcloseout ? #Compliance risks and #audit headaches ? Budget renegotiations and strained CRO relationships This webinar breaks down the difference between TMF management vs. oversight—and how to align Sponsor-CRO expectations from RFP to archive. ?? Key takeaways: ?? How to integrate TMF oversight into #contracts, #budgets & governance ?? How to avoid compliance pitfalls and ensure #auditreadiness ?? How to reduce last-minute resource burdens through early planning ?? Who should attend? This session is designed for?#ClinicalOperations,?#DataQuality?professionals,?#Statisticians,?#Clinicians, and?anyone who is looking to enhance compliance, reduce risks, and build stronger CRO partnerships. Join Katherine Hoover, Principal Consultant at Vital GXP Consulting, as she shares expert insights on #eTMF implementation, #risk-based quality management, and inspection readiness. Never miss an OccamPoint? Webinar—subscribe to our YouTube channel to catch past webinar Shorts! https://lnkd.in/gpR6ayhs Thank you to OccamPoint Webinar Sponsors! Stat4ward, Clinical Research Strategies, LLC, Telperian Inc Keliomics Trialwise, Inc. Harmonizing CRO and Sponsor Expectations in Outsourced TMF Management: ?? Wednesday, April 16, 2025 ?? 1:00 - 2:00 PM PST | 4:00 - 5:00 PM EST ?? Register: https://lnkd.in/gwvKZxnT

Biomarker Development?for Optimizing Pharmaceutical Programs and Portfolios. March 12, 2025. Join us to learn more about the importance of biomarkers in #pharmaceutical development at the next OccamPoint Webinar on March 12, 2025. The webinar is brought to you in partnership with Society of Decision Professionals (SDP) and highlights the value of #predictive #biomarker #data in drug development decision-making. Zoran Antonijevic, CSO of Bioforum the Data Masters will inform us of the benefits of #predictive #biomarkers to both #patients and #sponsors.?Zoran, an expert in #clinicaltrialdesign, #pharmaceutical #programstrategy, and #statistical consulting, will focus on the financial value of #biomarker #enrichment. He will discuss this value in the context of a single program, and then in the context of the whole portfolio, followed by an example of an #adaptive #enrichment #design. We will gain an understanding of #optimal #development #strategy through setting up #enrichment #decisioncriteria. Zoran brings decades of experience from designing well over 100 clinical trials that utilize innovative #adaptive and #platform designs. He has held senior leadership roles at organizations including Amgen, IQVIA, and Cytel, and is a well-published author. The webinar will be hosted by Lucia Mokres, Chief Fixer at Araneae Consulting.?Lucia is a #dynamic #problemsolver and the founder of Araneae, where she specializes in resolving #complex #operationalchallenges that hinder business performance, such as missed #milestones and unmet #goals. She believes that the most effective choices must be grounded in data and that taking the time to gather the right information is key to making informed, strategic decisions. Lucia is excited to host this webinar on biomarker-enriched drug development that focuses on data-based decision-making. Join us on March 12, 2025 at 1:00 pm (PDT)/4:00 pm (EDT) for an enlightening presentation; register at the link below: https://lnkd.in/gAcMj5X2 Julia Varshavsky, Ph.D. Jenny Chaplin, Zoran Antonijevic, Lucia Mokres, Gefen Shen, Sheila Babnis, Greg Ball, Beth Brinsdon, Mia D Champion, PhD, Mark G. Eller, Susan Gibson, Dean Gittleman, Shuguang Huang, Rick Landin, Elina Lavit, Corsee Sanders, Ph.D., Winifred Wu, Peng Yang, Rezi Zawadzki, Society of Decision Professionals (SDP), Frank Lau, MD, FACS

The traditional 3+3 design has been the go-to method for Phase I dose-finding trials, but is it the best approach? In this webinar, Professor Yuan Ji (University of Chicago) introduces the Generalized 3+3 (G3) design, a smarter, more flexible...

Gain valuable insights and strategies in clinical trial optimization with Slope’s Chief Revenue Officer, Ben Carmel, as he shares data on the current state of clinical trials and walks through the problems that lab manuals could be posing to clinical...

OccamPoint is a consortium of drug and combination product development professionals providing in-depth technical, regulatory and commercial expertise in healthcare and digital health. We are a team of executives, board members, coaches, and leaders...

Dr. Frank Lau, MD, FACS joins OccamPoint? Webinar to discuss paradigm-shifting organ-scale biology Keliomics platform that keeps human tissues alive ex-vivo for 8 weeks! The platform preserves the full composition, structure, and function of primary...

Artificial Intelligence is revolutionizing the landscape of modern medicine, bringing unprecedented efficiencies and insights to various aspects of healthcare. One of the most transformative applications of AI is in the realm of clinical trials, where...

Join Setareh Williams, PhD CMPP (Star Biopharma Consulting), as she shares her journey working with regulators to map and implement a regulatory and statistical strategy for real-world evidence study that closed efficacy and safety data evidence gaps...

OccamPoint Webinars and the Society of Decision Professionals (SDP) invite you to join them at the next webinar on March 12, 2025: Biomarker Development?for Optimizing Pharmaceutical Programs and Portfolios. Learn about the benefits of #predictive #biomarkers to both #patients and #sponsors from Zoran Antonijevic, CSO of Bioforum.?Dr Antonijevic, an expert in #clinicaltrialdesign, #pharmaceutical #programstrategy, and #statistical consulting, will focus on the financial value of #biomarker #enrichment. He will discuss this value in the context of a single program, and then in the context of the whole portfolio, followed by an example of an #adaptive #enrichment #design. We will gain an understanding of #optimal #development #strategy through setting up #enrichment #decisioncriteria. Zoran brings decades of experience from designing well over 100 clinical trials that utilize innovative #adaptive and #platform designs. He has held senior leadership roles at organizations including Amgen, IQVIA, and Cytel, and is a well-published author. The webinar will be hosted by Lucia Mokres, Chief Fixer at Araneae Consulting.?Dr. Mokres is a #dynamic #problemsolver and the founder of Araneae, where she specializes in resolving #complex #operationalchallenges that hinder business performance, such as missed #milestones and unmet #goals. Join us on March 12, 2025 at 1:00 pm (PDT)/4:00 pm (EDT) for an enlightening presentation; register at the link below: https://lnkd.in/gAcMj5X2 Julia Varshavsky, Ph.D. Jenny Chaplin, Zoran Antonijevic, Lucia Mokres, Gefen Shen, Sheila Babnis, Greg Ball, Beth Brinsdon, Mia D Champion, PhD, Mark G. Eller, Susan Gibson, Dean Gittleman, Shuguang Huang, Rick Landin, Elina Lavit, Corsee Sanders, Ph.D., Winifred Wu, Peng Yang, Rezi Zawadzki, Society of Decision Professionals (SDP), Frank Lau, MD, FACS